Close
Who We Are
Leadership Team
Board of Directors
Environmental, Social, and Governance (ESG) Commitment
Justice, Equity, Diversity, and Inclusion Commitment
Our Platform
Posters & Publications
Our Pipeline
Inflammatory Diseases
Patients, Families & Physicians
Investors & Media
News & Events
SEC Filings
Stock
Analyst Coverage
Governance
Careers
Contact Us
Skip to main content
Skip to footer
Evelo
Menu
Orally-administered EDP1815, a monoclonal strain of Prevotella histicola, has potent systemic anti-inflammatory effects without systemic exposure in mice and psoriasis patients
Home
/
Posters
December 26, 2019
by
November 11, 2019
by
«
Go to
Previous Page
Go to page
1
Go to page
2
Go to page
3